Cargando…
Injectable Materials for the Treatment of Myocardial Infarction and Heart Failure: The Promise of Decellularized Matrices
Cardiovascular disease continues to be the leading cause of death, suggesting that new therapies are needed to treat the progression of heart failure post-myocardial infarction. As cardiac tissue has a limited ability to regenerate itself, experimental biomaterial therapies have focused on the repla...
Autores principales: | Singelyn, Jennifer M., Christman, Karen L. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer US
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2933811/ https://www.ncbi.nlm.nih.gov/pubmed/20632221 http://dx.doi.org/10.1007/s12265-010-9202-x |
Ejemplares similares
-
Intra-articular injection of decellularized extracellular matrices in the treatment of osteoarthritis in rabbits
por: Zhang, Yaxin, et al.
Publicado: (2020) -
Designing Acellular Injectable Biomaterial Therapeutics for Treating Myocardial Infarction and Peripheral Artery Disease
por: Hernandez, Melissa J., et al.
Publicado: (2017) -
Proteomic and Bioinformatic Analysis of Decellularized Pancreatic Extracellular Matrices
por: Hu, Ming, et al.
Publicado: (2021) -
Acellular porcine heart matrices: whole organ decellularization with 3D-bioscaffold & vascular preservation
por: Ferng, Alice S., et al.
Publicado: (2017) -
APJ as Promising Therapeutic Target of Peptide Analogues in Myocardial Infarction- and Hypertension-Induced Heart Failure
por: Rossin, Daniela, et al.
Publicado: (2023)